Cantargia AB
Lund, Skane County, Sweden · Biopharma, Biotechnology, Health Care
Cantargia AB is a publicly traded biopharmaceutical company focused on the development of treatments for autoimmune and inflammatory diseases. The company works on innovative therapies leveraging its expertise in clinical development and regulatory strategies. It is dedicated to improving the quality of life for patients by addressing unmet medical needs.
Key facts
- Headquarters
- Lund, Skane County, Sweden
- Employees
- 22
- Industries
- Biopharma, Biotechnology, Health Care
- Status
- Private
- Website
- cantargia.com
- Company page
Recent activity at Cantargia AB
- : Cantargia AB Appoints Monic Stuart as Chief Medical Officer
- : Cantargia Appoints Dr Hilde Steineger as Chief Executive Officer
- : Cantargia Appoints Morten Lind Jensen as Chief Medical Officer
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
Leadership
- Ton Berkien, Chief Business Officer
- Monic Stuart, Chief Medical Officer
- Hilde Steineger, Chief Executive Officer
- Morten Lind Jensen, Chief Medical Officer
Verified email and direct lines for Cantargia AB’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.
Cantargia AB in the news
- Cantargia Presents Nomination Committee Ahead of 2027 AGM - Yahoo Finance (Oct 28, 2026)
- Cantargia to Present at the Stifel 2026 Healthcare Conference - Yahoo Finance (Oct 27, 2026)
- Cantargia: Early Haematology Signal Ahead of ASH Oral - TradingView (Nov 04, 2026)
- Cantargia to host Q3 2026 Interim Results Conference Call - Yahoo Finance (Nov 05, 2026)
- Cantargia Announces IL-17 as Second Target for Bispecific CAN14 Antibody - ACCESS Newswire (Nov 09, 2026)
- Cantargia (OM:CANTA) - Stock Analysis - Simply Wall St (Mar 09, 2018)
Companies similar to Cantargia AB
- Dimerix Limited · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- Newron Pharmaceuticals S.p.A. & EA Pharma Ltd · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- LAVA Therapeutics · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- OnCusp Therapeutics · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- BerGenBio ASA · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
About Cantargia AB: questions and answers
What does Cantargia AB do?
Cantargia AB is a publicly traded biopharmaceutical company focused on the development of treatments for autoimmune and inflammatory diseases. The company works on innovative therapies leveraging its expertise in clinical development and regulatory strategies. It is dedicated to improving the quality of life for patients by addressing unmet medical needs.
Where is Cantargia AB headquartered?
Cantargia AB is headquartered in Lund, Skane County, Sweden.
How many employees does Cantargia AB have?
Cantargia AB has about 22 employees.
Who leads Cantargia AB?
Hilde Steineger is a Chief Executive Officer at Cantargia AB.
What is the latest news on Cantargia AB?
On Oct 26, 2026, Cantargia AB Appoints Monic Stuart as Chief Medical Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy